Future Market Insights: Pharma and Healthcare Social Media Marketing Market Value and Growth 2015-2025

Submitted by: Submitted by

Views: 10

Words: 824

Pages: 4

Category: Business and Industry

Date Submitted: 09/28/2015 04:48 AM

Report This Essay

Global Pharma and

Healthcare Social Media

Marketing Market

Share, Global Trends,

Analysis, Research, Report,

Opportunities,

Segmentation and Forecast,

2015

Future Market Insights

www.futuremarketinsights.com

sales@futuremarketinsights.com

ReportDescription

Report Description

Social media platforms refer to the interaction among the people that involves creation,

sharing and exchange of information and ideas in virtual networks and communities.

However, use of these social media tools for marketing pharma content is still debatable.

The rationale behind this is that the regulatory teams of several pharma companies

demand the preventionof comments or sharing features resulting in only a one way

interaction,which in turn deprives theessence of social media marketing. However, with

the impact of these tools, there is an increased adoption rate of these platforms for

strategic decisions.

Browse Full Report@ http://www.futuremarketinsights.com/reports/pharma-andhealthcare-social-media-marketing-market

Efforts of pharma sector to leverage the benefits of social media tools to widen their

customer base, strengthen customer relationship and enhance brand performance

further fuels the usage of social media pharma and healthcare marketing. Other major

aspects favorable for pharma sector are building investor relations, corporate

communication and customer service at the corporate level. The involvement of

regulatory authorities in drafting and issuing guidance for use of interactive media for

drugs and biologics proves to be instrumental in deciding the importance of social media

marketing in pharma industry. For instance,in second week of January 2014, the U.S.

Food and Drug Administration (FDA) released a guidance draft for industry that needs to

fulfill the regulatory requirements for post marketing submissions of interactive

promotional media for animal and human drugs and biologics. Through this draft, the USFDA provided clarity on working with bloggers and content...